Search

everythinglearnresearchcommunity

for

Search:↓

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Too much androgen can cause hair loss; finasteride may help.

Male pattern baldness involves hormones and cell signals affecting hair growth.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

Hirsutism is more linked to high androgen levels than acne or hair loss, and a mix of hormonal tests is best for diagnosis; certain treatments can reduce symptoms.

Certain genetic variations in the AR and ERβ genes can affect androgen levels in women.

The conclusion is that managing androgen excess requires long-term treatment, including hormonal contraceptives and androgen blockers, with follow-up after six months.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Many young women who donate blood have hormonal disorders like excess male hormones and PCOS.

Bimatoprost, a glaucoma medication, may also help treat hair loss.

Androgen receptor activity blocks Wnt/β-catenin signaling, affecting hair growth and skin cell balance.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Hirsutism can be caused by various conditions besides PCOS, and it's important to treat the underlying issue and manage symptoms with medication and cosmetic approaches.

Androgen is important in controlling stem cell differentiation, reducing fat development, and increasing lean mass.

There is no significant link between male pattern baldness and insulin resistance.

Blocking the FGF5 gene in sheep leads to more fine wool and active hair follicles due to changes in certain cell signaling pathways.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

COVID-19 may harm male fertility and damage the reproductive system.

New treatments for prostate cancer are less toxic and show promise, but more research is needed to enhance their effectiveness and reduce side effects.

SARS-CoV-2, the virus causing COVID-19, can affect all endocrine organs and systems, altering their function and potentially leading to disorders. Factors like diabetes and obesity increase infection risk and severity. Understanding these effects is key for effective treatment.

Dutasteride and finasteride affect different cell types differently.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Saw palmetto supplements may reduce prostate cancer cell growth without being toxic.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

New biopsy techniques and tools improve alopecia diagnosis, and both too much and too little selenium can cause hair loss.